recurrent urinary tract infection Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting recurrent urinary tract infection clinical trials across 6 countries. Studies span Not Applicable, Phase 3, Phase 4, Phase 2. Top locations include Arnhem, Netherlands, Brooklyn, New York, United States, Budapest, Hungary. Updated daily from ClinicalTrials.gov.


recurrent urinary tract infection Trials at a Glance

8 actively recruiting trials for recurrent urinary tract infection are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Arnhem, Brooklyn, and Budapest. Lead sponsors running recurrent urinary tract infection studies include Hvidovre University Hospital, Jahn Ferenc South Pest Teaching Hospital, and Helsinki University Central Hospital.

Browse recurrent urinary tract infection trials by phase

Treatments under study

About recurrent urinary tract infection Clinical Trials

Looking for clinical trials for recurrent urinary tract infection? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new recurrent urinary tract infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about recurrent urinary tract infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

Prevention of Recurrent UTI Using Vaginal Testosterone Versus Placebo Placebo

Vaginal AtrophyPostmenopausal Disorderrecurrent urinary tract infection
Maimonides Medical Center100 enrolled1 locationNCT04807894
Recruiting
Not Applicable

A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections

Recurrent Urinary Tract InfectionsRecurrent UTIsRecurrent Urinary Tract Infections in Women+6 more
University of Texas Southwestern Medical Center90 enrolled1 locationNCT06940622
Recruiting
Not Applicable

Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment

Recurrent Urinary Tract Infections
Odense University Hospital80 enrolled2 locationsNCT04846803
Recruiting
Phase 3

Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in Women

Recurrent Urinary Tract Infections in Women
TCM Biotech International Corp.348 enrolled13 locationsNCT07184827
Recruiting

Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation

Bladder CancerInterstitial CystitisRecurrent Cystitis+5 more
Jahn Ferenc South Pest Teaching Hospital300 enrolled2 locationsNCT06719232
Recruiting
Phase 4

Gag Therapy for Recurrent Urinary Tract Infection Assessing Comparability to International Nitrofurantoin Gold Standard Study

recurrent urinary tract infection
Radboud University Medical Center100 enrolled3 locationsNCT05652374
Recruiting
Phase 2Phase 3

Faecal Microbiota Transplantation as Means of Preventing Recurrent Urinary Tract Infections

recurrent urinary tract infection
Helsinki University Central Hospital100 enrolled1 locationNCT06050148
Recruiting
Not Applicable

The Effect of ASTARTE™ on Recurrent Urinary Tract Infection

recurrent urinary tract infection
Hvidovre University Hospital720 enrolled1 locationNCT05553652